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ABSTRACT
Background: Ag-dependent activation of IgE-bearing mast cells is a critical first step in immediate hypersen-
sitivity and other allergic responses. Recent studies have revealed Ag-independent effects of monoclonal
mouse IgE molecules on mast cell survival and activation. However, no studies have been performed on the ef-
fects of polyclonal IgE molecules. Here, we tested whether polyclonal mouse and human IgE molecules affect
survival and cytokine production in mast cells.
Methods: Mast cells were cultured in the presence of polyclonal mouse and human IgE molecules, and cell
survival and cytokine production were analyzed.
Results: Polyclonal mouse IgE molecules in sera from mice with atopic dermatitis-like allergic skin inflamma-
tion, enhanced survival and cytokine production in mast cell cultures. Similar to the effects of monoclonal IgE,
the polyclonal IgE effects were mediated by the high-affinity IgE receptor, FcεRI. Human polyclonal IgE mole-
cules present in sera from atopic dermatitis patients were also capable of activating mast cells, and inducing IL-
8 production in human cord blood-derived mast cells.
Conclusions: These results imply that polyclonal IgE in atopic dermatitis and other atopic conditions might
modulate mast cell number and function, thus amplifying the allergic response.
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INTRODUCTION
Mast cells play a pivotal role in allergic inflammatory
reactions and in defense against certain bacteria and
parasites.1,2 In addition to these well-appreciated ar-
eas of mast cell function, recent studies have revealed
the roles of mast cells in innate and adaptive immu-
nity and implicated them in the pathogenesis of auto-
immune diseases, chronic heart failure, cancer, and
tolerance.3,4 Aggregation of FcεRI on mast cells by in-
teraction of receptor-bound IgE with multivalent Ag
induces their activation. Activated mast cells release a
variety of preformed and de novo synthesized proin-
flammatory and immunomodulatory mediators, such
as histamine, proteases, leukotrienes, prostaglandins,
and various cytokines and chemokines.2 In addition
to this classical IgE and Ag-dependent mechanism of
mast cell activation, we and others have observed
that survival and some activation events can also be
induced in mouse mast cells by monomeric IgE in
the absence of specific Ag.5,6 We also found that
mouse monoclonal IgE molecules are quite heteroge-
neous with respect to their ability to induce survival
and activation events in mouse mast cells7: at one end
of the spectrum, highly cytokinergic (HC) IgEs in-
duce enhanced survival, degranulation, adhesion, mi-
gration, and expression of cytokines such as IL-6 and
TNF-α; at the other extreme, poorly cytokinergic
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(PC) IgEs mediate these effector functions ineffi-
ciently.8 Human monoclonal IgE molecules also af-
fect human mast cells. Gilchrest et al. reported that
the chemokine I-309 mRNA and protein levels are
upregulated by IgE alone in the presence of IL-4.9
Cruse et al. observed that human monomeric IgE
stimulates cultured lung mast cells to release hista-
mine, leukotriene C4 and IL-8.10 In addition, it was re-
ported by Matsuda et al. that human monomeric IgE
enhances chemokine production in cultured human
mast cells, and this response was augmented by pre-
incubation of the cells in IL-4.11
The effects of monomeric IgE have mostly been
demonstrated by in vitro culture experiments, al-
though animal experiments have revealed that mouse
IgE molecules can also promote survival7 and migra-
tion12 of mouse mast cells in vivo as well as the
splenic mastocytosis induced by infestation with the
parasite Trichinella spiralis.13 In this study, we set out
to determine whether polyclonal IgE molecules in the
absence of a specific Ag can affect mast cell biology.
METHODS
MOUSE BONE MARROW-DERIVED MAST
CELLS (BMMCs)
Bone marrow cells from NCNga, C57BL6, and
FcεRIα−−14 mice were cultured in IL-3-containing me-
dium for 4 to 6 weeks to generate mast cells
(BMMCs) with more than 95% purity (c-Kit+FcεRI+ by
flow cytometry). Animal experiments were approved
by the Animal Care Committee of the La Jolla Insti-
tute for Allergy and Immunology (LIAI).
HUMAN CORD BLOOD-DERIVED MAST CELLS
(CBMCs)
Human CBMCs were generated as described.15
Briefly, CD34+ cells were purified from umbilical cord
blood mononuclear cells and cultured in serum-free
Iscove’s methylcellulose medium containing 200 ng
ml SCF, 50 ngml IL-6, 1 ngml IL-3, 1% insulin-
transferrin-selenium (Invitrogen, Carlsbad, CA, USA),
50 μM 2-mercaptoethanol, 1% penicillin-streptomycin
(Invitrogen), and 0.1% bovine serum albumin. On day
42 of culture, methylcellulose was dissolved in PBS
and the cells were then suspended and cultured in Is-
cove’s modified Dulbecco’s medium supplemented
with 100 ngml SCF, 50 ngml IL-6, and 5% fetal calf
serum. After 15 weeks, the purity of the resulting
CBMCs was ˜98% (c-Kit+FcεRI+ by flow cytometry).
SERUM PREPARATIONS AND PURIFICATION
OF IgE
Mouse sera were obtained from NCNga mice before
and after atopic dermatitis (AD)-like lesion induction
as described previously.16 Briefly, NCNga mice
were immunized by two rounds of epicutaneous treat-
ment with Dermatophagoides farinae extract (Der f,
Greer Laboratories, Lenoir, NC, USA) and Staphylo-
coccal enterotoxin B (SEB, Sigma-Aldrich, St. Louis,
MO, USA). Sera with high IgE levels were obtained
from mice with AD-like skin lesions with clinical skin
scores of8. In some experiments, mouse sera were
obtained from wild-type and IgE−− BALBc mice
epicutaneously immunized with ovalbumin (OVA) as
described previously.17 IgE concentrations were de-
termined by ELISA (BD Biosciences Pharmingen,
San Diego, CA, USA).
Human sera were obtained from AD patients and
normal subjects. Written informed consent was ob-
tained from all AD and normal subjects, and approved
by the Institutional Review Board of LIAI. Human IgE
levels were determined by latex agglutination-
turbidimetric immunoassay.18
For IgG or IgE depletion, sera were incubated
overnight at 4℃ with agarose beads chemically con-
jugated with either protein A (Amersham Bi-
osciences, Buckinghamshire, UK), anti-mouse IgE
mAb (Pharmingen) or anti-human IgE Ab (provided
by Dr. Ishizaka in LIAI). Sera were spun by microcen-
trifuge. Cleared sera were analyzed by SDS-PAGE fol-
lowed by immunoblotting with anti-mouse IgG Ab
(Amersham), anti-mouse IgE Ab (SouthernBiotech,
Birmingham, AL, USA) or anti-human IgE Ab (EMD
Biosciences Inc., La Jolla, CA, USA).
For purification of polyclonal IgE molecules from
sera, sera were pooled from AD-induced NCNga
mice and incubated with anti-mouse IgE-conjugated
agarose beads for overnight at 4℃. After incubation,
the beads were washed with PBS and eluted with 0.1
M glycine-HCl (pH 2.7). The eluted IgE molecules
were further purified by incubation with protein A
beads to exclude contaminated IgG molecules, and
followed by gel filtration chromatography using Su-
perdex S-200 column (Amersham) on an AKTApuri-
fierTM (GE Healthcare, Piscataway, NJ, USA) to pu-
rify monomeric IgE (Fig. 3A). After purification, IgE
preparation was dialyzed against PBS and concen-
trated by Microcon 10 (Millipore, Bedford, MA,
USA).
STIMULATION OF MAST CELLS WITH SERA
Mouse BMMCs (1 × 105 per 100 μl) in culture me-
dium containing 10% FCS were stimulated with sera
(10%) with high or low levels of IgE (from NCNga
mice untreated or treated with Der f and SEB; alter-
natively from BALBc or IgE−− mice epicutaneously
immunized with OVA) for 24 hours for cytokine
measurement or 72 hours for cell growth measure-
ment. When purified polyclonal IgE was used,
BMMCs were resuspended in culture medium and
stimulated by the polyclonal IgE (5 μgml) for 72
hours for the measurement of survival and cytokine
production. As controls, aliquots of BMMCs were
stimulated with 5 μgml of SPE-7 IgE (Sigma-Aldrich
Corp., St. Louis, MO, USA). For human CBMC ex-
periments, CBMCs (1 × 105) were first incubated
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Fig. 1 Efects of sera containing high IgE levels on mouse mast cels. BMMCs were incubated with 10% 
sera from AD-induced (AD) or normal-skin (non-AD) NC/Nga mice for 72 hours (A) or 24 hours (B). Some 
cels were also incubated with 5 μg/ml of SPE-7 IgE or medium alone (-). (A) Total live cel numbers were 
counted after trypan blue staining. (B) IL-6 and IL-13 secretions were measured by ELISA.
＊ p ＜0.05. ns, not significantly diferent; ＜d.l., less than detection limit.
with 100 ngml IL-4 (PeproTech Inc., Rocky Hill, NJ,
USA) for 24 hours to enhance FcεRI expression on
the cells.19 The cells were washed and resuspended
in culture medium. CBMCs were then stimulated
with sera (5 or 10%) from normal subjects or AD pa-
tients for 24 hours. As a positive control of activation,
some CBMCs were incubated with IL-4 together with
1 μgml human myeloma IgE (CosmoBio, Tokyo, Ja-
pan) for 24 hours and washed cells were stimulated
with anti-human IgE (Dako North America, Carpinte-
ria, CA, USA) for another 24 hours.
ELISA
Human IL-8 and mouse IL-6 were measured by
ELISA kits purchased from Biosource (Camarillo,
CA, USA) and Pharmingen, respectively.
IMMUNOBLOTTING
Immunoblotting was performed as described previ-
ously.20 Densitometry of phosphorylated and total
protein bands was performed using Quality OneⓇ
version 4.6.2 (Bio-Rad Laboratories, Hercules, CA,
USA).
STATISTICAL ANALYSIS
Differences between the 2 groups were analyzed by
paired or unpaired Student’s t-tests. A difference in p
value less than 0.05 was taken to indicate a statisti-
cally significant difference.
RESULTS
MOUSE POLYCLONAL IgE IN SERA CAN IN-
DUCE SURVIVAL PROMOTION AND CYTOKINE
PRODUCTION IN MOUSE MAST CELLS
We previously showed that a mixture of several mon-
oclonal IgE antibodies can promote survival and in-
duce cytokine production in mouse mast cells.7 How-
ever, no studies have been reported on the effect of
polyclonal IgE on mast cell biology. In order to ad-
dress this issue, we first tested whether sera contain-
ing high levels of IgE affect mast cell survival and cy-
tokine production. Sera with 43.3―58.5 μgml of IgE
derived from NCNga mice that had been treated
with Der f and SEB (AD sera)16 were added to
BMMC cultures at 10%. Cultures were kept without
IL-3. Sera with low levels (<0.5 μgml) of IgE from
non-treated NCNga mice (non-AD sera) served as a
control. Live mast cells decreased from 1 × 105 cells
to 4.5 × 104 cells after 72 hours in the absence of sera.
Non-AD sera failed to affect the number of live cells.
However, live mast cells were up to 80% more abun-
dant in BMMC cultures containing AD sera than in
cultures supplemented with non-AD sera (Fig. 1A).
The effect of AD sera on the production of IL-6 and
IL-13 was similarly greater than that of non-AD sera
(Fig. 1B).
To explore the specific role of IgE in these sera in
inducing mast cell survival and cytokine production,
we depleted IgE using rat anti-IgE beads and re-
peated the BMMC culture experiments. Nearly 100%
depletion of IgE was confirmed by immunoblotting
(Fig. 2A). As controls, sera pretreated with rat IgG
beads (negative control for IgE depletion) or protein
A (for IgG depletion) were tested. No detectable dif-
ferences in the effect on mast cell survival were seen
between non-treated sera and sera pretreated with rat
IgG beads (unpublished data). However, IgE-
depleted sera showed reduced effects on both mast
cell accumulation and cytokine production (Fig. 2B,
C): IgE depletion reduced the effect on mast accumu-
lation by 15―25% while it reduced the effect of IL-6
and IL-13 production by 22―30% and >90%, respec-
tively. IgG-depleted sera showed a tendency toward
reduction: the reduction in mast cell survival by IgG-
depleted sera did not reach statistical significance
(Fig. 2B), but IgG depletion induced a drastic reduc-
tion in IL-13 production (Fig. 2C). We observed the
positive effects of high concentrations of IgG on mast
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Fig. 2 Efects of IgE in mouse sera on mast cels. (A) Immunobloting of IgE- or IgG-depleted 
sera. (B, C) Efects of the sera were analyzed as in Figure 1. nd, non-depleted sera. (D) IL-6 pro-
duction by sera from epicutaneously OVA-immunized mice. ＜d.l., less than detection limit. (E-1) 
Sera from OVA-sensitized mice were first immunoprecipitated with anti-OVA antibody. Immune 
complexes precipitated with protein A agarose were divided into 9 parts and separately run on 
SDS gels together with supernatants (sera devoid of OVA), folowed by immunobloting with anti-
OVA antibody. (E-2) Sera from OVA-sensitized mice were analyzed for IgE and IgG levels by 
immunobloting. Arowhead, IgG heavy chain. ＊ p ＜0.05. ns, not significantly diferent.
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cell survival and cytokine production (unpublished
data), suggesting that the IgG effects stem from
stimulation of mast cells via the Fcγreceptors, prob-
ably FcγRIII andor FcγRIV.
Sera containing high levels of IgE were obtained
from another (BALBc) mouse model of AD induced
by epicutaneous sensitization with OVA.17 Sera were
also obtained in identically immunized IgE−− mice.
Sera from both WT and IgE−− mice induced IL-6 pro-
duction (Fig. 2D). However, the effect of sera from
IgE−− mice on IL-6 production to be at least 40% less.
These experiments, together with IgE depletion ex-
periments, demonstrate that IgE in sera can promote
mast cell survival and cytokine production in vitro.
POLYCLONAL IgEs IN SERA ARE MOSTLY
MONOMERIC AND NOT BOUND TO Ag
The observed effects of polyclonal IgE contained in
these sera could be mediated either by free IgE or by
Ag-bound IgE antibodies. To evaluate these possibili-
ties, we first examined whether sera derived from
OVA-immunized mice contain the Ag, OVA. OVA in
sera from WT mice was immunoprecipitated with
anti-OVA polyclonal antibody, and immune com-
plexes were precipitated with protein A-agarose
(proA in Fig. 2E-1). Immunoblot analysis of unpre-
cipitated supernatants (sup) and protein A precipi-
tates showed that there are no detectable levels of
OVA in sera (Fig. 2E-1). The size distribution of IgE
molecules in these sera were then examined. Analy-
sis by native PAGE and subsequent immunoblotting
revealed that more than 90% of IgE molecules in the
sera are present as a monomer (unpublished data).
This amount of monomeric IgE in sera is slightly
lower than those (>95%) of a typical highly cytokiner-
gic IgE, SPE-7, and a typical poorly cytokinergic IgE,
H1 DNP-ε-206, before these IgE preparations are ul-
tracentrifuged. Ultracentrifugation prior to experi-
mentation removes dimeric or oligomeric forms of
IgE (unpublished data).
Effects of Polyclonal IgE on Mast Cells
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Fig. 3 Mouse polyclonal IgE can induce mast cel accumulation via FcεRI. (A) BMMCs from WT 
and Fcε RIα -/- mice were incubated with the indicated sera. Live mast cels and cytokines were 
quantified. ＊ p ＜0.05. ns, not significantly diferent. (B, C) Immunoblot analysis of BMMCs stimu-
lated with SPE-7 IgE or sera from Der f/SEB-treated NC/Nga mice with antiphosphotyrosine mAb 
4G10 (B) or indicated antibodies (C). Ratio of phosphorylated to total protein intensities are 
shown. Results representing two independent experiments are shown.
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POLYCLONAL IgE TRANSDUCES ITS EFFECT
VIA FcεRI
The activating effects of monomeric IgE mAbs have
shown transduction via FcεRI.5 To test whether the
effect of polyclonal IgE in sera is also mediated by
FcεRI, we tested AD sera on BMMC derived from
FcεRIα−− mice. As expected, no differences were
seen in mast cell numbers and cytokine production
between non-treated and IgE-depleted sera (Fig. 3A,
Top). These results demonstrate that the effects of
polyclonal IgE in AD sera on mast cell survival and
cytokine production depend on FcεRI.
As would be expected for signaling via FcεRI, incu-
bation of WT cells with 10% sera containing high IgE
levels (‘AD sera’) induced tyrosine phosphorylation
of cellular proteins, similar to that induced by SPE-7
IgE (Fig. 3B). Phosphorylation patterns of LAT
(Y191), PLC-γ2 (Y1217), and p38 MAPK (T180Y182)
induced by ‘AD sera’ were generally comparable to
those induced by SPE-7 IgE (Fig. 3C). Importantly,
phosphoproteins induced by ‘AD sera’ were drasti-
cally reduced in FcεRIα−− cells, suggesting that
Kashiwakura JI et al.
416 Allergology International Vol 58, No3, 2009 www.jsaweb.jp
Fig. 4 Efects of purified polyclonal IgE on BMMCs. (A) Chromatogram of 
gel filtration during IgE purification. The fraction used for subsequent experi-
ments (indicated by a horizontal line) was analyzed by non-reducing SDS-
PAGE and Commassie blue staining (B). (C, D) This preparation (pIgEs) 
was added to cultures of BMMCs for 72 hours. Number of live mast cels 
and IL-6 production are shown. Note that IL-6 was not detected in super-
natants of BMMCs cultured in medium alone for 24 hours (Fig. 1B, 2D, & 
3A), but detected in those of BMMCs cultured in medium alone for 3 days 
(Fig. 4 C, D). ＊ p ＜0.05,＊＊ p ＜0.01.
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these phosphorylation events were caused mainly by
FcεRI-bound IgE in ‘AD sera’. However, phosphoryla-
tion patterns of Akt (S473) and ERK (T202Y204) in
WT were different between the two different stimuli
(Fig. 3C). Moreover, ‘AD sera’-induced phosphoryla-
tion patterns of Akt and ERK were similar in WT and
FcεRIα−− cells. These observations are consistent
with the idea that ‘AD sera’ contain a non-IgE fac-
tor(s) that can stimulate mast cells and induce phos-
phorylation of ERK and Akt. In addition, we found
that a non-IgE factor(s) induced strong tyrosine phos-
phorylation of 3 proteins in the range of 100―130 kDa
in FcεRIα−−, but not WT cells (Fig. 3B), suggesting
that FcεRIα regulates the cellular susceptibility to
such a factor(s). However, the identity of these
FcεRIα−− cell-specific tyrosine-phosphorylated pro-
teins remains to be determined.
PURIFIED POLYCLONAL IgE CAN INDUCE SUR-
VIVAL PROMOTION AND CYTOKINE PRODUC-
TION IN MOUSE MAST CELLS
The role of IgE (e.g.15―25% for mast cell accumula-
tion and 22―30% for IL-6 production) in the effect of
sera on mast cell survival and cytokine production
might initially appear to be modest. However, given
the possibility that sera, particularly from animals
with inflammation, contain many factors that might
modulate mast cell survival and proliferation, it is pos-
sible that IgE effects would be obscured by the back-
ground. Indeed, NCNga mice treated with Der f and
SEB had high mRNA levels of IL-4 (up to 40 fold over
non-treated control) and IL-6 (up to 3 fold) in draining
lymph nodes (T. Ando and T. K., unpublished data).
Therefore, these and other cytokines as well as other
protein and non-protein factors may be present in
such sera. However, IL-4 was shown to induce mast
cell apoptosis21 and therefore it was not surprising to
find that the relative contribution of IgE in sera to al-
terations in mast cell biology is limited. Indeed, IL-13
Effects of Polyclonal IgE on Mast Cells
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Fig. 5 Efects of human polyclonal IgE on mast cels. (A) Immunoblot 
analysis of IgE-depleted and non-depleted sera. (B) Human CBMCs were 
incubated with 10% IgE-depleted or non-depleted (nd) sera for 24 hours. IL-
8 production was measured by ELISA. Medium alone (-) in place of sera 
served as a control. ＊, ＊＊, ＊＊＊: p ＜0.05, p ＜0.01, p ＜0.001.
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production was reduced by more than 90% through
IgE depletion. To exclude the effects of the factors
that might affect mast cell biology, we purified mono-
meric IgE to near homogeneity by combining affinity
and gel filtration chromatographies from pooled sera
taken from Der fSEB-treated NCNga mice (Fig. 4
A, B). As shown in Figure 4C, D, the added polyclo-
nal IgE (at 5 μgml) in a monomeric form to mast cell
cultures in the absence of IL-3 or SCF promoted mast
cell survival and induced IL-6 production. The magni-
tude of these effects induced by polyclonal IgE was
intermediate between them elicited by SPE-7 and 206
IgEs, and similar to that induced by a mixture of vari-
ous HC and PC IgEs in a previous study.7
POLYCLONAL IgE CAN INDUCE IL-8 PRODUC-
TION IN HUMAN MAST CELLS
We and other investigators have reported that, simi-
lar to the effects of IgE on mouse mast cells, IgE anti-
bodies also modulate cytokine and chemokine pro-
duction in human mast cells.9-11 Therefore we evalu-
ated polyclonal IgE effects on IL-8 production in hu-
man CBMCs. Sera from AD patients (n = 8) were
used as a source of high-level polyclonal IgE (993―
24,194 IUml), while sera from non-AD individuals
(n = 2) were used as controls. Human CBMCs se-
creted higher amounts of IL-8 in the presence of 5%
or 10% AD sera than non-AD sera, although the differ-
ences in IL-8 production between AD and non-AD
sera varied considerably among CBMC preparations
(Fig. 5B and unpublished data). Depletion of IgE
from AD sera (Fig. 5A) reduced their effects on IL-8
production compared with that of non-depleted AD
sera (Fig. 5B). We conclude that polyclonal IgE can
affect chemokine production in human mast cells.
DISCUSSION
Ag-independent IgE effects on mast cell survival and
activation, as well as the heterogeneity of IgE mole-
cules in this regard, have been shown mainly using
mouse IgE mAbs (reviewed in ref.8). To the best of
our knowledge, this is the first study on the effects of
polyclonal IgE on mast cell biology. Polyclonal IgE
antibodies present in sera from mice with AD-like al-
lergic skin inflammation and polyclonal IgE purified
from the same sera can promote mouse mast cell sur-
vival and cytokine production, resembling mouse IgE
mAbs. Similar to mouse IgE mAbs, polyclonal IgE
also exerts its effect via the FcεRI. Our data under-
scores the role of IgE responses in mast cell sur-
vival.7,12,13 Similarly, AD sera containing high levels
of IgE induced IL-8 production in human CBMCs. In
this case, it is assumed that human FcεRI conveys the
effect of human monoclonal and polyclonal IgE mole-
cules in mast cells.
Ag-independent IgE effects on mast cell biology
have been shown to be mainly due to monomeric
IgE, but not IgE aggregates. In the past, various
groups have used FPLC or HPLC to independently
purify monomeric IgE and IgE aggregates from com-
mercial or laboratory preparations of IgE mAbs and
the effects of monomeric versus aggregate IgEs on
mast cell activation have been assessed.6,22,23 In the
present study, we purified monomeric, polyclonal IgE
using affinity and gel filtration chromatographies.
Our findings and previous observations by oth-
ers6,22,23 demonstrate that monomeric IgE exhibits
mast cell stimulatory activity regardless of IgE being
monoclonal or polyclonal. Although there is a remote
concern that IgE might aggregate in culture medium,
we believe this is unlikely, as demonstrated by bio-
physical simulations performed by Schweitzer-
Kashiwakura JI et al.
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Stenner and Pecht24. Additional concerns have been
raised that mast cells might be stimulated by IgE ad-
herent to plastic plates. However, such dependence
on plastic surfaces would be inconsistent with the ob-
servation that tyrosine phosphorylation and Ca2+ re-
sponses occur within seconds after IgE treat-
ment,22,23 and it would also be incompatible with our
findings concerning the heterogeneity of IgE mole-
cules with respect to mast cell activation.7 ELISA ex-
periments have confirmed that virtually no IgE is
bound to culture plates in these cultures (unpub-
lished data). Although the concept of ‘monomeric IgE
effects’ might still be considered as heretical by some
researchers, we have shown that monomeric IgE
mAbs induces aggregation of FcεRI,7 in the same
manner as IgE plus antigen, the conventionally ac-
cepted trigger of mast cell activation.
Our results also indicate that mouse sera contain-
ing high levels of IgE have a low degree of IgE aggre-
gates, at least when stored at 4℃ for a few weeks.
Previous studies showed that IgE aggregates in
preparations of IgE mAbs exhibit weak or strong
mast cell stimulatory activity.6,22,23 These observa-
tions suggest the possibility that in vivo mast cells in
inflammatory settings might be exposed to stimula-
tory effects not only of monomeric IgE, but also of
IgE oligomers even when specific Ag is not present.
Considering the fact that IgE is produced locally at
sites of allergic inflammation,25 it is possible that the
in vivo effects of IgE on mast cells may be signifi-
cantly greater than the 15―30% increases in mast cell
survival and cytokine production, which were ob-
served in cultures containing only 10% sera. The ac-
cumulation of splenic mast cells during infestation
with Trichinella spiralis, which elicits a robust IgE re-
sponse was enhanced more than two-folded in wild-
type mice compared with IgE−− mice.13 It is believed
that mast cells increased in the intestine of T. spiralis-
infected mice migrated to spleens then were elimi-
nated during the recovery phase. As the number of
jejunal mast cells was intact in IgE−− mice, it can be
interpreted that intestinal mast cell expansion in re-
sponse to T. spiralis-infection is not affected by IgE.
However, the number of splenic mast cells was re-
duced in IgE−− mice, probably due to lack of IgE-
mediated protection from apoptosis. Furthermore, we
have observed that IgE antibodies strongly promote
the accumulation of mast cells in the airways of mice
subjected to repeated inhalation of an aqueous ex-
tract of the allergen, Aspergillus fumigatus.26
Polyclonal IgE seems to be composed of HC and
PC IgE molecules. Compiled data indicate that 7 out
of 21 mouse IgE mAbs tested are HC IgEs, while the
remaining 14 mAbs are PC (unpublished data). The
potency of purified polyclonal IgE was intermediate
between those of HC and PC IgE mAbs (Fig. 4C, D).
These results are consistent with our previous find-
ings that the survival effects of a mixture of 6 mouse
mAbs were intermediate between HC and PC IgEs.7
Our findings on the effects of polyclonal IgE suggest
that patients with chronically high levels of IgEs
might have an expanded pool of mast cells that may
be subject to activating stimuli including polyclonal
IgE, with or without allergens. Mast cells in patients
who preferentially produce HC IgEs would be more
prone to activation than in patients who preferentially
produce PC IgEs.8 Although patients with PC IgEs
would probably benefit most by avoiding allergens,
those with high HC IgEs would not respond effec-
tively to such a strategy. Therefore, treating patients
who produce HC IgE but not PC IgE with anti-IgE
therapy would be a reasonable therapeutic approach.
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